Douglas E. Williams

2014 - Biogen

In 2014, Douglas E. Williams earned a total compensation of $5M as Former EVP, Research and Development at Biogen, a 4% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$859,413
Salary$739,112
Stock Awards$3,078,158
Other$370,365
Total$5,047,048

Williams received $3.1M in stock awards, accounting for 61% of the total pay in 2014.

Williams also received $859.4K in non-equity incentive plan, $739.1K in salary and $370.4K in other compensation.

Rankings

In 2014, Douglas E. Williams' compensation ranked 1,537th out of 13,032 executives tracked by ExecPay. In other words, Williams earned more than 88.2% of executives.

ClassificationRankingPercentile
All
1,537
out of 13,032
88th
Division
Manufacturing
549
out of 4,966
89th
Major group
Chemicals And Allied Products
174
out of 1,686
90th
Industry group
Drugs
135
out of 1,365
90th
Industry
Biological Products, Except Diagnostic Substances
19
out of 236
92nd
Source: SEC filing on April 15, 2016.

Williams' colleagues

We found seven more compensation records of executives who worked with Douglas E. Williams at Biogen in 2014.

2014

George Scangos

Biogen

Chief Executive Officer

2014

Alfred Sandrock

Biogen

Chief Medical Officer

2014

Adriana Karaboutis

Biogen

EVP, Technology and Business Solutions

2014

Adam Koppel

Biogen

SVP, Chief Strategy Officer

2014

Paul Clancy

Biogen

Chief Financial Officer

2014

John Cox

Biogen

EVP, Pharmaceutical Operations and Technology

2014

Stuart Kingsley

Biogen

Former EVP, Global Operations

News

You may also like